Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Depreciation and Depletion: 2013-2024

Historic Depreciation and Depletion for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to $3.9 million.

  • Collegium Pharmaceutical's Depreciation and Depletion rose 9.20% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 14.24%. This contributed to the annual value of $3.9 million for FY2024, which is 10.30% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Depreciation and Depletion is $3.9 million, which was up 10.30% from $3.5 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Depreciation and Depletion registered a high of $3.9 million during FY2024, and its lowest value of $870,000 during FY2020.
  • Over the past 3 years, Collegium Pharmaceutical's median Depreciation and Depletion value was $3.5 million (recorded in 2023), while the average stood at $3.3 million.
  • Data for Collegium Pharmaceutical's Depreciation and Depletion shows a peak YoY spiked of 99.54% (in 2021) over the last 5 years.
  • Over the past 5 years, Collegium Pharmaceutical's Depreciation and Depletion (Yearly) stood at $870,000 in 2020, then surged by 99.54% to $1.7 million in 2021, then surged by 54.61% to $2.7 million in 2022, then skyrocketed by 30.25% to $3.5 million in 2023, then increased by 10.30% to $3.9 million in 2024.